Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study is a prospective field evaluation to assess the effects of the chronic Intermittent Hypoxia exposure in 12 healthy humans.
Precisely, the study was designed to :
Set up a new model of Chronic Intermittent Hypoxia (CIH) applied to healthy human. This CIH is mimicking the CIH undergone by patients suffering from Sleep Apnea Syndrome.
Evaluate the cardiovascular effect of CIH. Neuronal and humoral sympathetic control, blood pressure control, vascular resistance.
Evaluate the Sleep quality, the ventilation under exposure and the long terms effect on ventilation control of CIH (central and peripheral chemoreflex).
Investigates the biological aspects of CIH exposure.
| Condition | Intervention |
|---|---|
|
Sleep Apnea Syndrome |
Other: Chronic Intermittent Hypoxia |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects |
- Blood Pressure [ Time Frame: Two Weeks ] [ Designated as safety issue: No ]
- Neuronal and humoral sympathetic control and vascular resistance. [ Time Frame: Two weeks ] [ Designated as safety issue: No ]
- Sleep quality [ Time Frame: Two Weeks ] [ Designated as safety issue: No ]
- The ventilation under exposure and the long terms effect on ventilation control of CIH (central and peripheral chemoreflex) [ Time Frame: two weeks ] [ Designated as safety issue: No ]
| Enrollment: | 12 |
| Study Start Date: | September 2005 |
| Estimated Study Completion Date: | October 2008 |
| Primary Completion Date: | July 2007 (Final data collection date for primary outcome measure) |
-
Other: Chronic Intermittent Hypoxia
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy subjects
Exclusion Criteria:
- Any history or significant medical condition
Contacts and Locations| France | |
| Pulmonary Function and sleep Lab, CHU Grenoble | |
| Grenoble, France, 38 000 | |
| Principal Investigator: | Renaud Tamisier, MD, PhD | University Hospital, Grenoble |
More Information
No publications provided
| Responsible Party: | TAMISIER Renaud, University Hospital, Grenoble |
| ClinicalTrials.gov Identifier: | NCT00746928 History of Changes |
| Other Study ID Numbers: | 05-CHUG-23 |
| Study First Received: | September 1, 2008 |
| Last Updated: | September 3, 2008 |
| Health Authority: | France: Institutional Ethical Committee France: Direction Générale de la Santé |
Keywords provided by University Hospital, Grenoble:
|
Blood pressure Hypertension sympathetic control chemosensitivity baroreflex |
Additional relevant MeSH terms:
|
Sleep Apnea Syndromes Anoxia Apnea Respiration Disorders Respiratory Tract Diseases Sleep Disorders, Intrinsic |
Dyssomnias Sleep Disorders Nervous System Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 21, 2013